Mitochondrial sirtuins: Emerging roles in metabolic regulations, energy homeostasis and diseases

Experimental Gerontology

Volumn 61, Issue , 2015, Pages 130-141

  Parihar, Priyanka ^a   Solanki, Isha ^a   Mansuri, Mohammad Lukman ^a   Parihar, Mordhwaj S ^a  

^a VIKRAM UNIVERSITY   (India)

Author keywords

Bioactive compounds; Cancer; Metabolic impairments; Mitochondrial sirtuins; Neurodegenerative diseases; Oxidative stress

Indexed keywords

ACETYL COENZYME A SYNTHETASE; ACETYL COENZYME A SYNTHETASE 2; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OROXYLIN A; PLANT MEDICINAL PRODUCT; PYRUVATE DEHYDROGENASE; PYRUVATE KINASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; RHAMNETIN; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; UNCLASSIFIED DRUG; VINIFERIN; FATTY ACID; SIRTUIN;

APOPTOSIS; BIOGENESIS; CITRIC ACID CYCLE; DEGENERATIVE DISEASE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY BALANCE; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; FATTY ACID OXIDATION; GLYCOLYSIS; HUMAN; METABOLIC DISORDER; METABOLIC REGULATION; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL RESPIRATION; NEOPLASM; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RESPIRATORY CHAIN; REVIEW; ANIMAL; ENERGY METABOLISM; HOMEOSTASIS; METABOLISM; MITOCHONDRION; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; APOPTOSIS; CITRIC ACID CYCLE; ENERGY METABOLISM; FATTY ACIDS; GLYCOLYSIS; HOMEOSTASIS; HUMANS; MITOCHONDRIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; SIRTUINS;

EID: 84919916896     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.12.004     Document Type: Review

References (153)

1. Ahn B.H., Kim H.S., Song S., Lee I.H., Liu J., Vassilopoulos A., Deng C.S., Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(38):14447-14452. 10.1073/pnas.0803790105.
2. Ahuja N., Schwer B., Carobbio S., Waltregny D., North B.J., Castronovo V., Maechler P., Verdin E. Regulation of insulin secretion by SIRT4, a mitochondrial ADP ribosyltransferase. J. Biol. Chem. 2007, 282(46):33583-33592. 10.1074/jbc.M705488200.
3. Allison S.J., Milner J. SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 2007, 6:2669-2677. 10.4161/cc.6.21.4866.
4. Ashraf N., Zino S., MacIntyre A., Kingsmore D., Payne A.P., George W.D., Shiels P.G. Altered sirtuin expression is associated with node-positive breast cancer. Br. J. Cancer 2006, 95:1056-1061. 10.1038/sj.bjc.6603384.
5. Bao J., Scott I., Lu Z., Pang L., Diamond C.C., Gius D., Sack M.N. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic. Biol. Med. 2010, 49:1230-1237.
6. Beal M.F. Less stress, longer life. Nat. Med. 2005, 11(6):598-599. 10.1038/nm0605-598.
7. Bell E.L., Guarente L. The SirT3 divining rod points to oxidative stress. Mol. Cell 2011, 42(5):561-568. (Review). 10.1016/j.molcel.2011.05.008.
8. Bell E.L., Emerling B.M., Ricoult S.J.H., Guarente L. SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011, 30:2986-2996. 10.1038/onc.2011.37.
9. Bellizzi D., Rose G., Cavalcante P., Covello G., Dato S., De Rango F., Greco V., Maggiolini M., Feraco E., Mari V., Franceschi C., Passarino G., De Benedictis G. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005, 85:258-263. 10.1016/j.ygeno.2004.11.003.
10. Brachmann C.B., Sherman J.M., Devine S.E., Cameron E.E., Pillus L., Boeke J.D. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 1995, 9:2888-2902. 10.1101/gad.9.23.2888.
11. Braissant O. Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine. Mol. Genet. Metab. 2010, 100(Suppl. 1):S53-S58. 10.1016/j.ymgme.2010.02.011.
12. Campbell C.T., Kolesar J.E., Kaufman B.A. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim. Biophys. Acta 2012, 1819(9-10):921-929. (Review). 10.1016/j.bbagrm.2012.03.002.
13. Chambers J.W., Maguire T.G., Alwine J.C. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 2009, 84(4):1867-1873. 10.1128/JVI. 02123-09.
14. Chen Y., Zhang J., Lin Y., Lei Q., Guan K.L., Zhao S., Xiong Y. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 2011, 12:534-541. 10.1038/embor.2011.65.
15. Chen Y., Fu L.L., Wen X., Wang X.Y., Liu J., Cheng Y., Huang J. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis. 2014, 5:e1047. 10.1038/cddis.2014.14.
16. Cheng Y., Ren X., Gowda A.S., Shan Y., Zhang L., Yuan Y.S., Patel R., Wu H., Huber-Keener K., Yang J.W., Liu D., Spratt T.E., Yang J.M. Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. Cell Death Dis. 2013, 4:e731. 10.1038/cddis.2013.254.
17. Choudhary C., Weinert B.T., Nishida Y., Verdin E., Mann M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 2014, 15:536-550. 10.1038/nrm3841.
18. Cimen H., Han M.J., Yang Y., Tong Q., Koc H., Koc E.C. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010, 19:49(2):304-311. 10.1038/nrm3841.
19. Cohen H.Y., Lavu S., Bitterman K.J., Hekking B., Imahiyerobo T.A., Miller C., Frye R., Ploegh H., Kessler B.M., Sinclair D.A. Acetylation of the C terminus of Ku70 by CBP and PCAF controls bax-mediated apoptosis. Mol. Cell 2004, 13:627-638. 10.1016/S1097-2765(04)00094-2.
20. de Moura M.B., Uppala R., Zhang Y., Van Houten B., Goetzman E.S. Overexpression of mitochondrial sirtuins alters glycolysis and mitochondrial function in HEK293 cells. PLoS One 2014, e106028. 10.1371/journal.pone.0106028.
21. Donmez G. The neurobiology of sirtuins and their role in neurodegeneration. Trends Pharmacol. Sci. 2012, 33:494-501. 10.1016/j.tips.2012.05.007.
22. Du J., Jiang H., Lin H. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD. Biochemistry 2009, 48(13):2878-2890. 10.1021/bi802093g.
23. Du J., Zhou Y., Su X., Yu J.J., Khan S., Jiang H., Kim J., Woo J., Kim J.H., Choi B.H., He B., Chen W., Zhang S., Cerione R.A., Auwerx J., Hao Q., Lin H. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011, 334:806-809. 10.1126/science.1207861.
24. Falcon A.A., Chen S., Wood M.S., Aris J.P. Acetyl-coenzyme A synthetase 2 is a nuclear protein required for replicative longevity in Saccharomyces cerevisiae. Mol. Cell. Biochem. 2010, 333:99-108. 10.1007/s11010-009-0209-z.
25. Finkel T., Deng C.X., Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460(7255):587-591. (Review). 10.1038/nature08197.
26. Finley L.W., Carracedo A., Lee J., Souza A., Egia A., Zhang J., Teruya-Feldstein J., Moreira P.I., Cardoso S.M., Clish C.B., Pandolfi P.P., Haigis M.C. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011, 19:416-428. 10.1016/j.ccr.2011.02.014.
27. Finley L.W., Haas W., Desquiret-Dumas V., Wallace D.C., Procaccio V., Gygi S.P., Haigis M.C. Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS One 2011, 6(8):e23295. 10.1371/journal.pone.0023295.
28. Flick F., Lüscher B. Regulation of sirtuin function by posttranslational modifications. Front. Pharmacol. 2012, 3:29. 10.3389/fphar.2012.00029.
29. Ford E., Voit R., Liszt G., Magin C., Grummt I., Guarente L. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 2006, 20(9):1075-1080. (1). 10.1101/gad.1399706.
30. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 1999, 260:273-279. 10.1006/bbrc.1999.0897.
31. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273(2):793-798. (5). 10.1006/bbrc.2000.3000.
32. Fu J., Jin J., Cichewicz R.H., Hageman S.A., Ellis T.K., Xiang L., Peng Q., Jiang M., Arbez N., Hotaling K., Ross C.A., Duan W. Trans-(-)-ε-viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington disease. J. Biol. Chem. 2012, 287(29):24460-24472. 10.1074/jbc.M112.382226.
33. Gan L., Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008, 58(1):10-14. (Review). 10.1016/j.neuron.2008.03.015.
34. Gerhart-Hines Z., Rodgers J.T., Bare O., Lerin C., Kim S.H., Mostoslavsky R., Alt F.W., Wu Z., Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 2007, 26:1913-1923. 10.1038/sj.emboj.7601633.
35. Gertz M., Nguyen G.T., Fischer F., Suenkel B., Schlicker C., Fränzel B., Tomaschewski J., Aladini F., Becker C., Wolters D., Steegborn C. A molecular mechanism for direct sirtuin activation by resveratrol. PLoS One 2012, 7(11):e49761. 10.1371/journal.pone.0049761.
36. Giralt A., Hondares E., Villena J.A., Ribas F., Diaz-Delfin J., Giralt M., Iglesias R., Villarroya F. Peroxisome proliferator-activated receptor-{gamma} coactivator-1{alpha} controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J. Biol. Chem. 2011, 286:16958-16966. 10.1074/jbc.M110.202390.
37. Gordan J.D., Simon M.C. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr. Opin. Genet. Dev. 2007, 17(1):71-77. (Review). 10.1016/j.gde.2006.12.006.
38. Guarente L. Sirtuins in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 2007, 72:483-488. 10.1101/sqb.2007.72.024.
39. Guarente L. The many faces of sirtuins: sirtuins and the Warburg effect. Nat. Med. 2014, 20:24-25. 10.1038/nm.3438.
40. Hafner A.V., Dai J., Gomes A.P., Xiao C., Palmeira C.M., Rosenzweig A., Sinclair D.A. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2010, 2(12):914-923.
41. Haigis M.C., Guarente L.P. Mammalian sirtuins emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006, 20:2913-2921. 10.1101/gad.1467506.
42. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 2010, 5:253-295. 10.1146/annurev.pathol.4.110807.092250.
43. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W., Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006, 126(5):941-954. (8). 10.1016/j.cell.2006.06.057.
44. Hallows W.C., Lee S., Denu J.M. Sirtuins deacetylate and activate mammalian acetyl CoA synthetases. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10230-10235. 10.1073/pnas.0604392103.
45. Hallows W.C., Yu W., Smith B.C., Devires M.K., Ellinger J.J., Someya S., Shortreed M.R., Prolla T., Markley J.L., Smith L.M., Zhao S., Guan K.L., Denu J.M. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 2011, 41:139-149. 10.1016/j.molcel.2011.01.002.
46. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., Hardie D.G. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2:28.1-28.16. 10.1186/1475-4924-2-28.
47. Hebert A.S., Dittenhafer-Reed K.E., Yu W., Bailey D.J., Selen Ebru Selin, Boersma M.D., Carson J.J., Tonelli M., Balloon A.J., Higbee A.J., Westphall M.S., Pagliarini D.J., Prolla T.A., Assadi-Porter Fariba, Roy S., Denu J.M., Coon J.J. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 2012, 49:186-199. 10.1016/j.molcel.2012.10.024.
48. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., Grueter C.A., Harris C., Biddinger S., Ilkayeva O.R., Stevens R.D., Li Y., Saha A.K., Ruderman N.B., Bain J.R., Newgard C.B., Farese R.V., Alt F.W., Kahn C.R., Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125. 10.1038/nature08778.
49. Hirschey M.D., Shimazu T., Huang J.Y., Schwer B., Verdin E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:267-277. 10.1101/sqb.2011.76.010850.
50. Hirschey M.D., Shimazu T., Jing E., Grueter C.A., Collins A.M., Aouizerat B., Stančáková A., Goetzman E., Lam M.M., Schwer B., Stevens R.D., Muehlbauer M.J., Kakar S., Bass N.M., Kuusisto J., Laakso M., Alt F.W., Newgard C.B., Farese R.V., Kahn C.R., Verdin E. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 2011, 44:177-190. 10.1016/j.molcel.2011.07.019.
51. Ho L., Titus A.S., Banerjee K.K., George S., Lin W., Deota S., Saha A.K., Nakamura K., Gut P., Verdin E., Kolthur-Seetharam U. Sirt4 regulates ATP homeostasis and mediates a retrograde signalling via AMPK. Aging 2013, 5(11):835-849.
52. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 2003, 23(24):9361-9374. 10.1128/MCB. 23.24.9361-9374.2003.
53. Huang J., Jia Y., Fu T., Viswakarma N., Bai L., Rao M.S., Zhu Y., Borensztajn J., Reddy J.K. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J. 2012, 26:628-638. 10.1096/fj.11-194019.
54. Jäger S., Handschin C., St-Pierre J., Spiegelman B.M. AMP activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC 1alpha. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(29):12017-12022. (17). 10.1073/pnas.0705070104.
55. Jeppesen M.G., Navratil T., Spremulli L.L., Nyborg J. Crystal structure of the bovine mitochondrial elongation factor Tu.Ts complex. J. Biol. Chem. 2005, 280:5071-5081. 10.1074/jbc.M411782200.
56. Ji H., Friedman M.I. Reduced capacity for fatty acid oxidation in rats with inherited susceptibility to diet-induced obesity. Metab. Clin. Exp. 2007, 56(8):1124-1130. 10.1016/j.metabol.2007.04.006.
57. Jiang H., Khan S., Wang Y., Charron G., He B., Sebastian C., Du J., Kim R., Ge E., Mostoslavsky R., Hang H.C., Hao Q., Lin H. Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine. Nature 2013, 496(7443):110-113. 10.1038/nature12038.
58. Jing E., O'Neill B.T., Rardin M.J., Kleinridders A., Ilkeyeva O.R., Ussar S., Bain J.R., Lee K.Y., Verdin E.M., Newgard C.B., Gibson B.W., Kahn C.R. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 2013, 62(10):3404-3417. 10.2337/db12-1650.
59. Jornayvaz F.R., Shulman G.I. Regulation of mitochondrial biogenesis. Essays Biochem. 2010, 47:69-84. (Review). 10.1042/bse0470069.
60. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1(1):15-25. (Review). 10.1016/j.cmet.2004.12.003.
61. Kaidi A., Weinert B.T., Choudhary C., Jackson S.P. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 2010, 329(5997):1348-1353. (10). 10.1126/science.1192049.
62. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., McCord R.A., Ongaiqui K.C., Boxer L.D., Chang H.Y., Chua K.F. SIRT6 links histone H3 lysine 9 deacetylation to NF-κB-dependent gene expression and organismal life span. Cell 2009, 136:62-74. 10.1016/j.cell.2008.10.052.
63. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607-618. 10.1016/j.molcel.2006.06.026.
64. Kim H.S., Patel K., Muldoon-Jacobs K., Bisht K.S., Aykin-Burns N., Pennington J.D., van der Meer R., Nguyen P., Savage J., Owens K.M., Vassilopoulos A., Ozden O., Park S.H., Singh K.K., Abdulkadir S.A., Spitz D.R., Deng C.X., Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52. 10.1016/j.ccr.2009.11.023.
65. Kim H.S., Lu H.F., Alano C.C. Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture. PLoS One 2011, 6(3):e14731. 10.1371/journal.pone.0014731.
66. Kong X., Wang R., Xue Y., Liu X., Zhang H., Chen Y., Fang F., Chang Y. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010, 5(7):e11707. 10.1371/journal.pone.0011707.
67. Laurent G., German N.J., Saha A.K., de Boer V.C., Davies M., Koves T.R., Dephoure N., Fischer F., Boanca G., Vaitheesvaran B., Lovitch S.B., Sharpe A.H., Kurland I.J., Steegborn C., Gygi S.P., Muoio D.M., Ruderman N.B., Haigis M.C. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol. Cell 2013, 50(5):686-698. (6). 10.1016/j.molcel.2013.05.012.
68. Law I.K., Liu L., Xu A., Lam K.S., Vanhoutte P.M., Che C.M., Leung P.T., Wang Y. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics 2009, 9:2444-2456. 10.1002/pmic.200800738.
69. Li S., Banck M.A., Mujtaba S.A., Zhou M.M.A., Sugrue M.M.A., Walsh M. p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS One 2010, 5:e10486. 10.1371/journal.pone.0010486.
70. Liu B., Che W., Xue J., Zheng C., Tang K., Zhang J., Wen J., Xu Y. SIRT4 prevents hypoxia-induced apoptosis in H9c2 cardiomyoblast cells. Cell. Physiol. Biochem. 2013, 32(3):655-662. 10.1159/000354469.
71. Liu L., Nam M., Fan W., Akie T.E., Hoaglin D.C., Gao G., Keaney J.F., Cooper M.P. Nutrient sensing by the mitochondrial transcription machinery dictates oxidative phosphorylation. J. Clin. Invest. 2014, 124(2):768-784. 10.1172/JCI69413.
72. Lomb D.J., Laurent G., Haigis M.C. Sirtuins regulate key aspects of lipid metabolism. Biochim. Biophys. Acta 2010, 1804(8):1652-1657. 10.1016/j.bbapap.2009.11.021.
73. Lombard D.B., Alt F.W., Cheng H.L., Bunkenborg J., Streeper R.S., Mostoslavsky R., Kim J., Yancopoulos G., Valenzuela D., Murphy A., Yang Y., Chen Y., Hirschey M.D., Bronson R.T., Haigis M., Guarente L.P., Farese R.V., Weissman S., Verdin E., Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 2007, 27(24):8807-8814. 10.1128/MCB. 01636-07.
74. Lombard D.B., Schwer B., Alt F.W. Mostoslavsky R. SIRT6 in DNA repair, metabolism and ageing. J. Intern. Med. 2008, 263(2):128-141. 10.1111/j.1365-2796.2007.01902.x.
75. Luk E., Carroll M., Baker M., Culotta V.C. Manganese activation of superoxide dismutase 2 in Saccharomyces cerevisiae requires MTM1, a member of the mitochondrial carrier family. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(18):10353-10357. 10.1073/pnas.1632471100.
76. Matsushita N., Yonashiro R., Ogata Y., Sugiura A., Nagashima S., Fukuda T., Inatome R., Yanagi S. Distinct regulation of mitochondrial localization and stability of two human Sirt5 isoforms. Genes Cells 2011, 16(2):190-202. 10.1111/j.1365-2443.2010.01475.x.
77. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 2005, 16:4623-4635. 10.1091/mbc.E05-01-0033.
78. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L.A., Barrett J.C., Chang H.Y., Bohr V.A., Ried T., Gozani O., Chua K.F. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008, 452(7186):492-496. (27). 10.1038/nature06736.
79. Michishita E., McCord R.A., Boxer L.D., Barber M.F., Hong T., Gozani O., Chua K.F. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 2009, 8(16):2664-2666. 10.4161/cc.8.16.9367.
80. Milne J.C., Denu J.M. The sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 2008, 12:11-17. 10.1016/j.cbpa.2008.01.019.
81. Muller F.L., Liu Y., Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 2004, 279(47):49064-49073. (19). 10.1074/jbc.M407715200.
82. Nakagawa T., Lomb D.J., Haigis M.C., Guarente L. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137(3):560-570. (1). 10.1016/j.cell.2009.02.026.
83. Nakamura Y., Ogura M., Ogura K., Tanaka D., Inagaki N. SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice. FEBS Lett. 2012, 586(23):4076-4081. 10.1016/j.febslet.2012.10.009.
84. Nakatani Y., Ogryzko V. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 2003, 370:430-444. 10.1016/S0076-6879(03)70037-8.
85. Nasrin N., Wu X., Fortier E., Feng Y., Bare O.C., Chen S., Ren X., Wu Z., Streeper R.S., Bordone L. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 2010, 285(42):31995-32002. (15). 10.1074/jbc.M110.124164.
86. Newman J.C., He W., Verdin E. Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J. Biol. Chem. 2012, 287(51):42436-42443. 10.1074/jbc.R112.404863.
87. Ngo H.B., Kaiser J.T., Chan D.C. The mitochondrial transcription and packaging factor Tfam imposes a U-turn on mitochondrial DNA. Nat. Struct. Mol. Biol. 2011, 18(11):1290-1296. (30). 10.1038/nsmb.2159.
88. North B.J., Marshall B.L., Borra M.T., Denu J.M., Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Molecular cell 2003, 11(2):437-444. 10.1016/S1097-2765(03)00038-8.
89. North B.J., Sinclair D.A. Sirtuins: a conserved key unlocking AceCS activity. Trends Biochem. Sci. 2007, 32:1-4. 10.1016/j.tibs.2006.11.002.
90. North B.J., Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 2004, 5(5):224. 10.1186/gb-2004-5-5-224.
91. Olmos Y., Valle I., Borniquel S., Tierrez A., Soria E., Lamas S., Monsalve M. Mutual dependence of Foxo3a and PGC-1α in the induction of oxidative stress genes. J. Biol. Chem. 2009, 284:14476-14484. 10.1074/jbc.M807397200.
92. Onyango P., Celic I., McCaffery J.M., Boeke J.D., Feinberg A.P. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(21):13653-13658. 10.1073/pnas.222538099.
93. Palacios O.M., Carmona J.J., Michan S., Chen K.Y., Manabe Y., Ward J.L., Goodyear L.J., Tong Q. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1α in skeletal muscle. Aging 2009, 1(9):771-783.
94. Papa L., Germain D. Sirt3 regulates the mitochondrial unfolded protein response. Mol. Cell. Biol. 2014, 34(7):1378. 10.1128/MCB. 01337-13.
95. Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell 2013, 50(6):919-930. 10.1016/j.molcel.2013.06.001.
96. Park E.S., Kang J.C., Jang Y.C., Park J.S., Jang S.Y., Kim D.E., Kim B., Shin H.S. Cardioprotective effects of rhamnetin in H9c2 cardiomyoblast cells under H2O2-induced apoptosis. J. Ethnopharmacol. 2014, (Epub ahead of print). 10.1016/j.jep.2014.02.019.
97. Pedersen P.L., Mathupala S., Rempel A., Geschwind J.F., Ko Y.H. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta 2002, 1555(1-3):14-20. (10). 10.1016/S0005-2728(02)00248-7.
98. Pellegrini L., Pucci B., Villanova L., Marino M.L., Marfe G., Sansone L., Vernucci E., Bellizzi D., Reali V., Fini M., Russo M.A., Tafani M. SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ. 2012, 19(11):1815-1825. 10.1038/cdd.2012.62.
99. Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y., He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C., Dai J., Verdin E., Ye Y., Zhao Y. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell. Proteomics 2011, 10:1-12. (M111.012658). 10.1074/mcp.M111.012658.
100. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N. Engl. J. Med. 2004, 350:664-671. 10.1056/NEJMoa031314.
101. Pillai V.B., Sundaresan N.R., Kim G., Gupta M., Rajamohan S.B., Pillai J.B., Samant S., Ravindra P.V., Isbatan A., Gupta M.P. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 2010, 285:3133-3144. 10.1074/jbc.M109.077271.
102. Qiu X., Brown K., Hirschey M.D., Verdin E., Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010, 12(6):662-667. (1). 10.1016/j.cmet.2010.11.015.
103. Rayalam S., Yang J.Y., Ambati S., Della-Fera M.A., Baile C.A. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother. Res. 2008, 22(10):1367-1371. 10.1002/ptr.2503.
104. Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607. 10.2337/diab.37.12.1595.
105. Samant S.A., Zhang H.J., Hong Z., Pillai V.B., Sundaresan N.R., Wolfgeher D., Archer S.L., Chan D.C., Gupta M.P. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol. Cell. Biol. 2014, 34(5):807-819. 10.1128/MCB. 01483-13.
106. Sanders B.D., Jackson B., Marmorstein R. Structural basis for sirtuin function: what we know and what we don't. Biochim. Biophys. Acta 2010, 1804:1604-1616. 10.1016/j.bbapap.2009.09.009.
107. Sauve A.A., Youn D.Y. Sirtuins: NAD(+)-dependent deacetylase mechanism and regulation. Curr. Opin. Chem. Biol. 2012, 16(5-6):535-543. 10.1016/j.cbpa.2012.10.003.
108. Scher M.B., Vaquero A., Reinberg D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev. 2007, 21:920-928. 10.1101/gad.1527307.
109. Schirmer H., Pereira T.C., Rico E.P., Rosemberg D.B., Bonan C.D., Bogo M.R., Souto A.A. Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish liver. Mol. Biol. Rep. 2012, 39(3):3281-3289. 10.1007/s11033-011-1096-4.
110. Schlicker C., Gertz M., Papatheodorou P., Kachholz B., Becker C.F., Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 2008, 382(3):790-801. (10). 10.1016/j.jmb.2008.07.048.
111. Schumacker P.T. SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF. Cancer Cell 2011, 19:299-300. 10.1016/j.ccr.2011.03.001.
112. Schwer B., Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008, 7:104-112. 10.1016/j.cmet.2007.11.006.
113. Schwer B., North B.J., Frye R.A., Ott M., Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 2002, 158(4):647-657. (19). 10.1083/jcb.200205057.
114. Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl CoA synthetase 2. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(27):10224-10229. (5). 10.1073/pnas.0603968103.
115. Schwer B., Eckersdorff M., Li Y., Silva J.C., Fermin D., Kurtev M.V., Giallourakis C., Comb M.J., Alt F.W., Lombard D.B. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 2009, 8:604-606. 10.1111/j.1474-9726.2009.00503.x.
116. Seagroves T.N., Ryan H.E., Lu H., Wouters B.G., Knapp M., Thibault P., Laderoute K., Johnson R.S. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol. Cell. Biol. 2001, 21(10):3436-3444. 10.1128/MCB. 21.10.3436-3444.2001.
117. Shi T., Wang F., Stieren E., Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 2005, 280(14):13560-13567. (8). 10.1074/jbc.M414670200.
118. Shi T., Fan G.Q., Xiao S.D. SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. J. Dig. Dis. 2010, 11:55-62. 10.1111/j.1751-2980.2009.00416.x.
119. Shimazu T., Hirschey M.D., Hua L., Dittenhafer-Reed K.E., Schwer B., Lombard D.B., Li Y., Bunkenborg J., Alt F.W., Denu J.M., Jacobson M.P., Verdin E. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 2010, 12(6):654-661. (1). 10.1016/j.cmet.2010.11.003.
120. Shulga N., Pastorino J.G. Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J. Cell Sci. 2010, 123:4117-4127. 10.1242/jcs.073502.
121. Shulga N., Wilson-Smith R., Pastorino J.G. Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J. Cell Sci. 2010, 123:894-902. 10.1242/jcs.061846.
122. Siegel A.B., Zhu A.X. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009, 115:5651-5661. 10.1002/cncr.24687.
123. Signorelli P., Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 2005, 16(8):449-466. (Review). 10.1016/j.jnutbio.2005.01.017.
124. Someya S., Yu W., Hallows W.C., Xu J., Vann J.M., Leeuwenburgh C., Tanokura M., Denu J.M., Prolla T.A. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010, 143:802-812. 10.1016/j.cell.2010.10.002.
125. Stobbe M.D., Wanders R.J.A., Van Kampen A.H.C., Houten S.M., Moerland P.D. Improving the description of metabolic networks: the TCA cycle as example. FASEB J. 2012, 26(9):3625-3636. 10.1096/fj.11-203091.
126. Sundaresan N.R., Samant S.A., Pillai V.B., Rajamohan S.B., Gupta M.P. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol. Cell. Biol. 2008, 28:6384-6401. 10.1128/MCB. 00426-08.
127. Sundaresan N.R., Gupta M., Kim G., Rajamohan S.B., Isbatan A., Gupta M.P. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 2009, 119:2758-2771. 10.1172/JCI39162.
128. Tao R., Coleman M.C., Pennington J.D., Ozden O., Park S.H., Jiang H., Kim H.S., Flynn C.R., Hill S., Hayes, with McDonald W.H., Olivier A.K., Spitz D.R., Gius D. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 2010, 40:893-904. 10.1016/j.molcel.2010.12.013.
129. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410(6825):227-230. (8). 10.1038/35065638.
130. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389(6651):610-614. 10.1038/39335.
131. Vakhrusheva O., Smolka C., Gajawada P., Kostin S., Boettger T., Kubin T., Braun T., Bober E. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 2008, 102(6):703-710. (28). 10.1161/CIRCRESAHA.107.164558.
132. Vander Heiden M.G., Lewis C.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324(5930):1029-1033. 10.1126/science.1160809.
133. Vaquero A., Scher M.B., Lee D.H., Sutton A., Cheng H.L., Alt F.W., Serrano L., Sternglanz R., Reinberg D. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 2006, 20(10):1256-1261. (15). 10.1101/gad.1412706.
134. Vassilopoulos A., Pennington J.D., Andresson T., Rees D.M., Bosley A.D., Fearnley I.M., Ham A., Flynn C.R., Hill S., Rose K.L., Kim H.S., Deng C.X., Walker J.E., Gius D. SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress. Antioxid. Redox Signal. 2014, (Epub ahead of print). 10.1089/ars.2013.5420.
135. Vempati R.K., Jayani R.S., Notani D., Sengupta A., Galande S., Halder D. p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J. Biol. Chem. 2010, 285:28553-28564. 10.1074/jbc.M110.149393.
136. Verdin E., Hirschey M.D., Finley L.W., Haigis M.C. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem. Sci. 2010, 35(12):669-675. (Review). 10.1016/j.tibs.2010.07.003.
137. Wang C., Chen L., Hou X., Li Z., Kabra N., Ma Y., Nemoto S., Finkel T., Gu W., Cress W.D., Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 2006, 8:1025-1031. 10.1038/ncb1468.
138. Wang Z., Cotney J., Shadel G.S. Human mitochondrial ribosomal protein MRPL12 interacts directly with mitochondrial RNA polymerase to modulate mitochondrial gene expression. J. Biol. Chem. 2007, 282:12610-12618. 10.1074/jbc.M700461200.
139. Wang F., Nguyen M., Qin F.X., Tong Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 2007, 6(4):505-514. 10.1111/j.1474-9726.2007.00304.x.
140. Wang Q., Zhang Y., Yang C., Xiong H., Lin Y., Yao J., Li H., Xie L., Zhao W., Yao Y., Ning Z.B., Zeng R., Xiong Y., Guan K.L., Zhao S., Zhao G.P. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 2010, 327:1004-1007. 10.1126/science.1179687.
141. Warburg O. On the origin of cancer cells. Science 1956, 123(3191):309-314. 10.1126/science.123.3191.309.
142. Wei L., Zhou Y., Dai Q., Qiao C., Zhao L., Hui H., Lu N., Guo Q.L. Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma. Cell Death Dis. 2013, 4:e601. 10.1038/cddis.2013.131.
143. Weir H.J.M., Murray T.K., Kehoe P.G., Seth L., Verdin E., Michael O'Neill, Jon L., Balthasar N. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PLoS One 2012, 7:e48225. 10.1371/journal.pone.0048225.
144. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689. 10.1038/nature02789.
145. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008. 10.1016/j.cub.2003.10.031.
146. Xue L., Xu F., Meng L., Wei S., Wang J., Hao P., Bian Y., Zhang Y., Chen Y. Acetylation-dependent regulation of mitochondrial ALDH2 activation by SIRT3 mediates acute ethanol-induced eNOS activation. FEBS Lett. 2012, 586:137-142. 10.1016/j.febslet.2011.11.031.
147. Yáñez M., Fraiz N., Cano E., Orallo F. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenalin and 5-hydroxytryptamine uptake and of monoamine oxidase activity. Eur. J. Pharmacol. 2006, 542(1-3):54-60. 10.1016/j.ejphar.2006.06.005.
148. Yang B., Zwaans B.M., Eckersdorff M., Lombard D.B. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle 2009, 8(16):2662-2663. (15). 10.4161/cc.8.16.9329.
149. + dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J. Biol. Chem. 2010, 285(10):7417-7429. (5). 10.1074/jbc.M109.053421.
150. Yu W., Dittenhafer-Reed K.E., Denu J.M. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J. Biol. Chem. 2012, 287:14078-14086. 10.1074/jbc.M112.355206.
151. Yu J., Sadhukhan S., Noriega L.G., Moullan N., He B., Weiss R.S., Lin H., Schoonjans K., Auwerx J. Metabolic characterization of a Sirt5 deficient mouse model. Sci. Rep. 2013, 3:2806. 10.1038/srep02806.
152. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L., Chin J., Yang P., Chen X., Lei Q., Xiong Y., Guan K.L. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004. 10.1126/science.1179689.
153. Zhong L., Mostoslavsky R. Fine tuning our cellular factories: sirtuins in mitochondrial biology. Cell Metab. 2011, 13(6):621-626. (8, Review). 10.1016/j.cmet.2011.05.004.